Health Condition 1: C67- Malignant neoplasm of bladder
Conditions
Interventions
Intervention1: Intravesical Gemcitabine: Immediate single time Intravesical instillation with a hold up time of 1 hour post TURBT in the post operative period in Non-Muscle
Invasive Bladder Cancer
Co
Sponsors
Akhilesh Sharma
Eligibility
Inclusion criteria
Inclusion criteria: More than equal to 18 years of age Patient providing written informed consent Cystoscopically looking NMIBC Cystoscopically complete resection of tumour done
Exclusion criteria
Exclusion criteria: Active significant Haematuria in the post operative period Bladder Perforation Extensive Resection done Previously proven MIBC patients Any high grade or more than two low grade NMIBC in the last 18 months Previous or concurrent upper urinary tract or prostatic urethral cancer Pregnant or lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the recurrence rates at the end of 6 months with Intravesical Gemcitabine and Mitomycin C as Immediate Intravesical Therapy post TURBT in Non-Muscle Invasive Bladder Cancer patients.Timepoint: At the end of 6 months after single dose of Intravesical Gemcitabine and Mitomycin C post TURBT in Non-Muscle Invasive Bladder Cancer patients | — |
Secondary
| Measure | Time frame |
|---|---|
| To study the treatment related Adverse effects with the use of Intravesical Gemcitabine & Mitomycin C as Immediate Intravesical Therapy post TURBTTimepoint: Post instillation of drug on Post Operative Day One & subsequent follow up till 6 months | — |
Countries
India
Contacts
Public ContactAkhilesh Sharma
AIIMS Rishikesh
Outcome results
None listed